Hazard Identification: This step involves identifying the potential
toxicity and other hazards associated with specific nanomaterials.
Exposure Assessment: Estimating the extent to which humans and the environment may be exposed to nanomaterials.
Dose-Response Assessment: Determining the relationship between the dose of the nanomaterial and the severity of the adverse effect.
Risk Characterization: Integrating the information from the previous steps to estimate the overall risk.
Data Gaps: Limited data on the
long-term effects of exposure to nanomaterials.
Measurement Difficulties: Challenges in accurately measuring
exposure levels and concentrations of nanoparticles.
Complex Interactions: The interactions between nanomaterials and biological systems can be complex and not yet fully understood.
Standardization: The lack of standardized methods for testing and evaluating nanomaterials.
Informed Decision-Making: Provides a scientific basis for regulatory decisions and helps in the safe design of nanomaterials.
Risk Management: Helps in developing strategies to mitigate potential risks.
Public Confidence: Enhances public confidence in the safety of nanotechnology products.
Enhanced Research: Investing in research to better understand the properties and effects of nanomaterials.
Standardization: Developing standardized methods for testing and evaluating nanomaterials.
Collaboration: Promoting collaboration between researchers, industry, and regulators to share data and best practices.
Advanced Tools: Utilizing advanced computational models and tools to predict the behavior and risks of nanomaterials.
